Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL

Avadel Pharmaceuticals (AVDL) Stock Price & Analysis

504 Followers

AVDL Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.05 - $10.20
Previous Close$8.52
Volume1.50M
Average Volume (3M)521.48K
Market Cap
$575.64M
Enterprise Value$558.15M
Total Cash (Recent Filing)$106.47M
Total Debt (Recent Filing)$138.27M
Price to Earnings (P/E)-3.7
Beta1.05
May 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.29
Shares Outstanding61,778,732
10 Day Avg. Volume331,033
30 Day Avg. Volume521,476
Standard Deviation0.28
R-Squared0.08
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-19.28
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)16.60
P/FCF Ratio-10.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-5.79
Forecast
Price Target Upside65.73% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

AVDL FAQ

What was Avadel Pharmaceuticals’s price range in the past 12 months?
Avadel Pharmaceuticals lowest stock price was $1.05 and its highest was $10.20 in the past 12 months.
    What is Avadel Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Avadel Pharmaceuticals’s upcoming earnings report date?
    Avadel Pharmaceuticals’s upcoming earnings report date is May 08, 2023 which is in 38 days.
      How were Avadel Pharmaceuticals’s earnings last quarter?
      Avadel Pharmaceuticals released its earnings results on Mar 30, 2023. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of -$0.265 by -$0.175.
        Is Avadel Pharmaceuticals overvalued?
        According to Wall Street analysts Avadel Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Avadel Pharmaceuticals pay dividends?
          Avadel Pharmaceuticals does not currently pay dividends.
          What is Avadel Pharmaceuticals’s EPS estimate?
          Avadel Pharmaceuticals’s EPS estimate is -$0.32.
            How many shares outstanding does Avadel Pharmaceuticals have?
            Avadel Pharmaceuticals has 61,778,732 shares outstanding.
              What happened to Avadel Pharmaceuticals’s price movement after its last earnings report?
              Avadel Pharmaceuticals reported an EPS of -$0.44 in its last earnings report, missing expectations of -$0.265. Following the earnings report the stock price went down -4.162%.
                Which hedge fund is a major shareholder of Avadel Pharmaceuticals?
                Among the largest hedge funds holding Avadel Pharmaceuticals’s share is Brandes Investment Partners LP. It holds Avadel Pharmaceuticals’s shares valued at 12M.

                  ---

                  Avadel Pharmaceuticals Stock Smart Score

                  The Avadel Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Avadel Pharmaceuticals

                  Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

                  ---

                  Top 5 ETFs holding AVDL

                  Name
                  Market Value
                  Smart Score
                  Fidelity Nasdaq Composite Index ETF
                  $292.31K
                  8
                  Up to five ETFs with an Outperform Smart Score that hold AVDL. The ETFs are listed according to market value of AVDL within the ETF

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Jazz Pharmaceuticals
                  Perrigo Company
                  GH Research
                  Mallinckrodt public limited company

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis